D. Ashcroft

First name
D.
Middle name
M.
Last name
Ashcroft
Joseph, R. M., Knaggs, R. D., Coupland, C. A. C., Taylor, A., Vinogradova, Y., Butler, D., et al. (2023). Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records. Bmc Geriatr, 23, 435. http://doi.org/10.1186/s12877-023-04143-2
Chen, T. C., Iskandar, I. Y. K., Parisi, R., Pierce, M., Tower, C., Kleyn, C. E., et al. (2023). Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK. Jama Dermatol. http://doi.org/10.1001/jamadermatol.2023.1400
Trafford, A. M., Carr, M. J., Ashcroft, D. M., Chew-Graham, C. A., Cockcroft, E., Cybulski, L., et al. (2023). Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population-based study. Lancet Child Adolesc Health. http://doi.org/10.1016/s2352-4642(23)00126-8
Fahmi, A., Wong, D., Walker, L., Buchan, I., Pirmohamed, M., Sharma, A., et al. (2023). Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: Large variability in risks of adverse drug related and emergency hospital admissions. Plos One, 18, e0281466. http://doi.org/10.1371/journal.pone.0281466
Abo-Tabik, M., Parisi, R., Morgan, C., Willis, S., Griffiths, C. E., & Ashcroft, D. M. (2022). Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies. Br J Gen Pract, 72, e834-e841. http://doi.org/10.3399/bjgp.2022.0137
Abo-Tabik, M., Parisi, R., Morgan, C., Willis, S., Griffiths, C. E., & Ashcroft, D. M. (2022). Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies. Br J Gen Pract. http://doi.org/10.3399/bjgp.2022.0137
Domzaridou, E., Carr, M. J., Webb, R. T., Millar, T., & Ashcroft, D. M. (2022). Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records. Lancet Reg Health Eur, 22, 100489. http://doi.org/10.1016/j.lanepe.2022.100489
Zghebi, S. S., Reeves, D., Grigoroglou, C., McMillan, B., Ashcroft, D. M., Parisi, R., & Kontopantelis, E. (2022). Clinical code usage in UK general practice: a cohort study exploring 18 conditions over 14 years. Bmj Open, 12, e051456. http://doi.org/10.1136/bmjopen-2021-051456
Cybulski, L., Ashcroft, D. M., Carr, M. J., Garg, S., Chew-Graham, C. A., Kapur, N., & Webb, R. T. (2022). Management of anxiety disorders among children and adolescents in UK primary care: A cohort study. J Affect Disord, 313, 270-277. http://doi.org/10.1016/j.jad.2022.07.002
Ajabnoor, A. M., Zghebi, S. S., Parisi, R., Ashcroft, D. M., Rutter, M. K., Doran, T., et al. (2022). Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study. Plos Med, 19, e1004003. http://doi.org/10.1371/journal.pmed.1004003